On Nov 9, 2021 Alltrna closed a Venture – Series Unknown round and raised $50,000,000 from Flagship Pioneering, featuring lead investors Flagship Pioneering. About the […]
Seed Round – Home Biosciences
On Nov 9, 2021 Home Biosciences closed a Seed round and raised $15,000,000 from Redmile Group, Sofinnova Partners, featuring lead investors Redmile Group, Sofinnova Partners. […]
Series E – Color
On Nov 9, 2021 Color closed a Series E round and raised $100,000,000 from Emerson Collective, General Catalyst, Kindred Ventures, T. Rowe Price, Viking Global […]
Grant – Strand Therapeutics
On Nov 9, 2021 Strand Therapeutics closed a Grant round and raised $400,000 from National Cancer Institute, featuring lead investors National Cancer Institute. About the […]
Grant – DNA Script
On Nov 9, 2021 DNA Script closed a Grant round and raised $2,200,000 from National Human Genome Research Institute, featuring lead investors National Human Genome […]
Post-IPO Equity – AnPac Bio-Medical Science
On Nov 9, 2021 AnPac Bio-Medical Science closed a Post-IPO Equity round and raised $2,900,000 from investors, featuring lead investors . About the company: AnPac […]
Series A – Mekonos
On Nov 9, 2021 Mekonos closed a Series A round and raised $25,000,000 from Debiopharm Innovation Fund, Elementum Ventures, Fiscus Ventures, Novartis, PEAK6 Investments, Reimagined […]
Seed Round – 3Bar Biologics
On Nov 9, 2021 3Bar Biologics closed a Seed round and raised $250,000 from S2G Ventures, featuring lead investors S2G Ventures. About the company: 3Bar […]
Venture Round – Truveta
On Nov 9, 2021 Truveta closed a Venture – Series Unknown round and raised $100,000,000 from investors, featuring lead investors . About the company: Truveta […]
Series B – Arbor Biotechnologies
On Nov 9, 2021 Arbor Biotechnologies closed a Series B round and raised $215,000,000 from Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Deep Track […]
